イムノオンコロジーアッセイ市場：製品別、技術別、適応症別、用途別、地域別

世界のイムノオンコロジーアッセイ市場は、2024年に49億8,000万米ドルと推定され、2024年から2031年までのCAGRは11.2％を示し、2031年には104億7,000万米ドルに達すると予測されます。

図.イムノオンコロジーアッセイ市場シェア（%）、地域別、2024年

イムノオンコロジーアッセイは、がん免疫療法に関連するタンパク質のような生体分子の発現解析に役立ちます。これらのアッセイは、腫瘍のプロファイリング、治療戦略、免疫療法の開発に役立ちます。免疫バイオマーカーの発現を評価することで、がんと免疫の相互作用に関する重要な洞察が得られ、標的治療の方向性が示されます。プロテオミクス、ゲノム解析、マルチプレックス技術などの分野の進歩により、ハイスループットイムノオンコロジーアッセイの開発が可能になった。既存の抗腫瘍免疫応答を測定し、治療結果を予測するこれらの能力は、精密腫瘍学において不可欠なツールとなっています。

市場力学：

世界のイムノオンコロジーアッセイ市場の成長は、標的がん治療に対する需要の高まり、併用免疫療法の採用の増加、製薬企業による研究開発投資の増加、コンパニオン診断検査の利用可能性の向上などの要因によって牽引されています。しかし、免疫腫瘍学検査に関連する高額なコストや、こうした検査に対する償還の制限といった市場抑制要因もあります。一方、バイオマーカー研究の進行と手頃な免疫腫瘍学的検査法の開発は、市場参入者にとって大きなビジネスチャンスです。

本調査の主な特徴

• 本レポートでは、世界のイムノオンコロジーアッセイ市場を詳細に分析し、2023年を基準年とした予測期間（2024-2031年）の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益成長機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界のイムノオンコロジーアッセイ市場の主要企業をプロファイルしています。
• 主要企業は、Charles River Laboratories、F. Hoffmann-La Roche Ltd、llumina, Inc.、Agilent Technologies, Inc.、Thermo Fisher Scientific Inc.、Merck KGaA、Invivoscribe, Inc、QIAGEN、PerkinElmer Inc.、Sartorius AG、Bio-Rad Laboratories, Inc.、Bruker Spatial Biology, Inc.、Nexelis、Reaction Biology、Crown Bioscience、HTG Molecular Diagnostics, Inc.、Axion BioSystems, Inc.、BioTherapeutics LLCなどです。
• 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
• イムノオンコロジーアッセイの世界市場は、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。
• 利害関係者は、世界のイムノオンコロジーアッセイ市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 主な発展
• 規制シナリオ
• 買収と提携のシナリオ
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界のイムノオンコロジーアッセイ市場- コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界のイムノオンコロジーアッセイ市場、製品別、2019年-2031年

• 消耗品
• ソフトウェア

第6章 世界のイムノオンコロジーアッセイ市場、技術別、2019年-2031年

• 免疫測定
• PCR
• 次世代シーズ
• フローサイトメトリー
• その他

第7章 世界のイムノオンコロジーアッセイ市場、適応症別、2019年-2031年

• 大腸がん
• 肺がん
• 悪性黒色腫
• 膀胱がん
• その他

第8章 世界のイムノオンコロジーアッセイ市場、用途別、2019年-2031年

• 臨床診断
• 研究開発

第9章 世界のイムノオンコロジーアッセイ市場、地域別、2019年-2031年

第10章 競合情勢

• 企業プロファイル
  • Charles River Laboratories
  • F. Hoffmann-La Roche Ltd
  • llumina, Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Invivoscribe, Inc.
  • QIAGEN
  • PerkinElmer Inc.
  • Sartorius AG
  • Bio-Rad Laboratories, Inc.
  • Bruker Spatial Biology, Inc.
  • Nexelis
  • Reaction Biology
  • Crown Bioscience
  • HTG Molecular Diagnostics, Inc.
  • Axion BioSystems, Inc
  • BioTherapeutics LLC

第11章 アナリストの提言

• Wheel of Fortune
• アナリストの見解
• Coherent Opportunity Map

第12章 参考文献と調査手法

• 参考文献
• 調査手法

Global immuno-oncology assays market is estimated to be valued at USD 4.98 Bn in 2024 and is expected to reach USD 10.47 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.2% from 2024 to 2031.

Figure. Immuno-Oncology Assays Market Share (%), By Region, 2024

Immuno-oncology assays help analyze the expression of biomolecules like proteins that are relevant for cancer immunotherapies. These assays aid in tumor profiling, treatment strategies, and development of immunotherapies. They help evaluate expression of immune biomarkers, which provides crucial insights into cancer-immune interactions and offers direction for targeted therapies. Advancements in fields like proteomics, genomic analysis, and multiplex technologies have enabled development of high-throughput immuno-oncology assays. Their ability to gauge pre-existing antitumor immune responses and predict treatment outcomes makes them integral tools in precision oncology.

Market Dynamics:

The global immuno-oncology assays market growth is driven by factors such as growing demand for targeted cancer therapies, rising adoption of combinational immunotherapies, increasing R&D investments by pharmaceutical companies, and improving availability of companion diagnostic tests. However, the market faces restraints in terms of high costs associated with immuno-oncology assays and limited reimbursement for such tests. Meanwhile, ongoing research on biomarkers and development of affordable immuno-oncology assays present significant opportunities for market players.

Key Features of the Study:

• This report provides an in-depth analysis of the global immuno-oncology assays market and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global immuno-oncology assays market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this includes Charles River Laboratories, F. Hoffmann-La Roche Ltd, llumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck KGaA, Invivoscribe, Inc., QIAGEN, PerkinElmer Inc., Sartorius AG, Bio-Rad Laboratories, Inc., Bruker Spatial Biology, Inc., Nexelis, Reaction Biology, Crown Bioscience, HTG Molecular Diagnostics, Inc., Axion BioSystems, Inc, and BioTherapeutics LLC
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global immuno-oncology assays market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immuno-oncology assays market

Detailed Segmentation-

• By Product:
  • Consumables
  • Software
• By Technology:
  • Immunoassay
  • PCR
  • NGS
  • Fow Cytometry
  • Others
• By Indication:
  • Colorectal Cancer
  • Lung Cancer
  • Melanoma
  • Bladder Cancer
  • Others
• By Application:
  • Clinical Diagnostics
  • Research and Development
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Charles River Laboratories
  • Hoffmann-La Roche Ltd
  • llumina, Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Invivoscribe, Inc.
  • QIAGEN
  • PerkinElmer Inc.
  • Sartorius AG
  • Bio-Rad Laboratories, Inc.
  • Bruker Spatial Biology, Inc.
  • Nexelis
  • Reaction Biology
  • Crown Bioscience
  • HTG Molecular Diagnostics, Inc.
  • Axion BioSystems, Inc
  • BioTherapeutics LLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Technology
  • Market Snapshot, By Indication
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Immuno-Oncology Assays Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Immuno-Oncology Assays Market, By Product, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Consumables
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Software
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Immuno-Oncology Assays Market, By Technology, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Immunoassay
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• PCR
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• NGS
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Fow Cytometry
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Immuno-Oncology Assays Market, By Indication, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Colorectal Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Lung Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Melanoma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Bladder Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Immuno-Oncology Assays Market, By Application, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Clinical Diagnostics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Research and Development
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Immuno-Oncology Assays Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profiles
  • Charles River Laboratories*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F. Hoffmann-La Roche Ltd
  • llumina, Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Invivoscribe, Inc.
  • QIAGEN
  • PerkinElmer Inc.
  • Sartorius AG
  • Bio-Rad Laboratories, Inc.
  • Bruker Spatial Biology, Inc.
  • Nexelis
  • Reaction Biology
  • Crown Bioscience
  • HTG Molecular Diagnostics, Inc.
  • Axion BioSystems, Inc
  • BioTherapeutics LLC

11. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact